chevron_leftBack
As of 15 June 2026, Teyi Pharmaceutical Group Co.,Ltd has a market cap of $732.12M USD, ranking #12643 globally and #3784 in China.
It ranks #1153 in the Healthcare sector, and #429 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$732.12MUSD
4.96B CNY
Enterprise Value
$722.32MUSD
4.89B CNY
Revenue (TTM)
$136.44MUSD
924.53M CNY
EBITDA (TTM)
$22.26MUSD
150.64M CNY
Net Income (TTM)
$12.05MUSD
81.67M CNY
EBITDA Margin
16%
Profit Margin
8.8%
PE Ratio
62.1
PS Ratio
5.4
PB Ratio
2.7
EV/EBITDA
32.5
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Danqing Xu
open_in_new
Employees
1,434
Founded
2002
Website
tczy.com.cn
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0% | -5.5% | -10% | -23% | -10% | 28% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
002728
特一药业集团股份有限公司 Class A
ISIN: CNE100001WK6
Shares Out.:
Shares Outstanding:
318.196M1
Shares Float:
275.157M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
9.93 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Teyi Pharmaceutical Group Co.,Ltd
Teyi Pharmaceutical Group Co.,Ltd engages in the research and development, production, and sale of Chinese patented medicines, pharmaceutical preparations, raw materials, and products in the People’s Republic of China. The company’s products are used in respiratory system, cardiovascular and cerebrovascular, respiratory, cardiovascular, and digestive systems. The company was formerly known as Guangdong Taicheng Pharmaceutical Co., Ltd. and changed its name to Teyi Pharmaceutical Group Co.,Ltd in November 2016. The company was founded in 2002 and is based in Taishan, the People’s Republic of China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SSE: 600276
|
$53.85B
7K%
364.89B CNY
|
44.9
|
|
SSE: 603259
|
$49.64B
7K%
336.36B CNY
|
17.2
|
|
SHEK: 3692
|
$28.52B
4K%
223.48B HKD
|
35.7
|
|
SHEK: 1801
|
$18.8B
2K%
147.32B HKD
|
162.3
|
|
SSE: 688506
|
$16.51B
2K%
111.89B CNY
|
-
|
|
SHEK: 9926
|
$16.01B
2K%
125.46B HKD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
104K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
75K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
49K%
|
97.4
|
|
SIX: RO
|
$321.52B
44K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$288.84B
39K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.65B
37K%
218.9B CHF
|
20.5
|
chevron_leftBack